BOSTON, Aug. 12, 2022 (GLOBE NEWSWIRE) — GreenLight Biosciences (NASDAQ:GRNA), a public benefit corporation striving to bring effective and safe solutions to make food clean and affordable for everyone and dedicated to developing health solutions for every person on our planet, today announced a private placement of approximately $109 million.
Chamath Palihapitiya’s SPAC Nearly Doubles Following Business Combo With Video Game Therapeutics Company
Special purpose acquisition company Social Capital Suvretta Holdings Corp. I (NASDAQ: DNAA), sponsored by U.S.-Canadian venture capitalist Chamath Palihapitiya, jumped nearly 200% in after-hours trading on Friday.
